Key result
Higher HDL-C/apoA-I ratio links to worse coronary stenosis but not MACE in diabetic ACS patients.
Why the study?
Distinct lipid profiles and their relationships with coronary artery stenosis severity and prognosis in ACS patients with T2DM remain elusive.
Is the HDL-C/apoA-I ratio associated with the severity of coronary artery stenosis and prognosis in ACS patients with T2DM?
Cohort (n=468)
No
Is the HDL-C/apoA-I ratio associated with the severity of coronary artery stenosis and prognosis in ACS patients with T2DM?
A higher HDL-C/apoA-I ratio is associated with increased severity of coronary artery stenosis in diabetic patients with ACS, but does not predict 2-year major adverse cardiovascular events.
Does not support routine HDL-C/apoA-I use for risk stratification in diabetic ACS; leaves open mechanistic and prognostic validation.
BACKGROUND: Emerging evidence demonstrates that the lipid metabolism in acute coronary syndrome (ACS) patients with type 2 diabetes mellitus (T2DM) differs from nondiabetic patients. However, the distinct lipid profiles and their relationships with the severity of coronary artery stenosis and prognosis in patients with T2DM remain elusive. METHOD AND RESULT: This single-center, prospective cohort study enrolled 468 patients diagnosed with ACS undergoing coronary angiography, consisting of 314 non-DM and 154 DM patients. The HDL-C/apoA-I ratio was significantly higher in DM patients with a multivessel (≥3 affected vessels) lesion than a single-vessel (1-2 affected vessels) lesion. Regression analyses showed that the HDL-C/apoA-I ratio was positively correlated to the number of stenotic coronary arteries in DM patients but not non-DM patients. However, Kaplan-Meier survival analysis revealed no significant difference in the major adverse cardiovascular event rate regarding different HDL-C/apoA-I levels in DM or non-DM ACS patients at the end of the 2-year follow-up. CONCLUSION: A higher HDL-C/apoA-I ratio is associated with increased severity of coronary artery stenosis in DM patients with ACS but not with the rate of major adverse cardiovascular events at the end of the 2-year follow-up.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2021) conducted a cohort in Acute coronary syndrome (ACS) with or without type 2 diabetes mellitus (T2DM) (n=468). HDL-C/apoA-I ratio vs. Lower HDL-C/apoA-I ratio / non-diabetic patients was evaluated on Severity of coronary artery stenosis and major adverse cardiovascular events. A higher HDL-C/apoA-I ratio was associated with increased severity of coronary artery stenosis in diabetic patients with ACS, but not with major adverse cardiovascular events at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: